Corneal transplantation improves bilateral vision in paediatric patients

Article

Corneal transplantation is generally successful in infants, children and adolescents

A recent study published in Ophthalmology shows corneal transplantation is generally successful in infants, children and adolescents.

Dr Keryn A. Williams et al., Department of Ophthalmology, Flinders Medical Centre, Australia, conducted a prospective cohort study on 14 865 records of penetrating corneal grafts in 11 929 patients. Of these records, 765 grafts in 640 patients aged 20 and below were used. Records from the Australian Corneal graft Registry were investigated using Kaplan-Meier survival plots and Cox proportional hazards regression analysis. The main outcome measures included the probability of corneal graft survival and Snellen acuity at certain intervals and at the last follow-up post-graft.

It was found that adolescents, of ages 13 to 19 years old, experienced the best corneal graft survival and infants, who were less than 5 years old, demonstrated the lowest corneal graft survival of all the study group. Factors influencing paediatric patient's corneal graft survival included indication for graft, graft inflammation, history of intraocular surgery, vascularization, rejection episodes, post-graft operative procedures and refractive surgery.

The findings suggested although overall bilateral vision is improved, infants showed low visual outcomes and it was concluded that both corneal graft survival and visual outcomes are affected more by graft indication than the patient's age.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.